Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma - Lowe, P J; Tannenbaum, S; Gautier, A (Br J Clin Pharmacol, 2009)
et al.